Walleye Capital
SYRA

Walleye Capital’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Walleye Capital’s Portfolio SYRA Stock Details SYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-54,910
Closed -$56K – 6003
2023
Q4 		$56K Sell
54,910
-41,435
-43% -$63.9K ﹤0.01% 4262
2023
Q3 		$289K Buy
+96,345
New +$289K ﹤0.01% 3269

Other funds holding SYRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Capital's SYRA Position: Q1 2024 in Review

Walleye Capital sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q1 2024, closing a stake of 54,910 shares — an estimated $56K sold.

Walleye Capital first reported a position in SYRA in Q3 2023 and held it in 2 quarters. The position peaked at $289K in Q3 2023. 9 funds tracked by Wall St. Rank hold SYRA as of Q1 2024.

  • Walleye Capital reported no remaining Syra Health Corp. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 54,910 Syra Health Corp. Class A Common Stock shares in Q1 2024, an estimated $56K.
  • Walleye Capital first reported a position in Syra Health Corp. Class A Common Stock in Q3 2023 and held it in 2 quarters.
  • Walleye Capital's Syra Health Corp. Class A Common Stock position peaked at $289K in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.